Forty-two (42) voided urine samples from patients with active bladder cancer (TCC), prostate cancer (CAP), renal cancer (RCC), healthy subjects and urine from patients with suspected TCC which were found positive for nonmalignant conditions (NMC) by pathology, were analyzed for the presence of DEK protein. This evidence concerns the gene DEK and renal cell carcinoma.